Opposite effects of a single versus repeated doses of gabapentin on retention performance of an inhibitory avoidance response in mice

Neurobiology of Learning and Memory

Volumn 87, Issue 2, 2007, Pages 192-200

  Blake, Mariano G ^a   Boccia, Mariano M ^a   Acosta, Gabriela B ^b   Höcht, Christian ^a   Baratti, Carlos M ^a  

^a Facultad de Farmacia y Bioquimica   (Argentina)

^b CONICET ^*  (Argentina)

Author keywords

Acetylcholine; Consolidation; Gabapentin; Inhibitory avoidance; Memory; Mice; Retrieval

Indexed keywords

ANTICONVULSIVE AGENT; CHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; GABAPENTIN; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CHOLINE UPTAKE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HIPPOCAMPUS; MALE; MEMORY; MEMORY CONSOLIDATION; MEMORY RETRIEVAL; MOUSE; NONHUMAN; REPEATED DRUG DOSE; SINGLE DRUG DOSE; TASK PERFORMANCE; TRAINING;

AMINES; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CHOLINE; CONDITIONING, CLASSICAL; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; INHIBITION (PSYCHOLOGY); MALE; MICE; MUSCARINIC AGONISTS; OXOTREMORINE; REACTION TIME; TRITIUM;

EID: 33845915684     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2006.08.006     Document Type: Article

References (42)

1. Acosta G.B., Boccia M.M., and Baratti C.M. Gabapentin, an antiepileptic drug, improves memory storage in mice. Neuroscience Letters 279 (2000) 173-176
2. Baratti C.M., Huygens P., Miño J., Merlo A., and Gardella J. Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice. Psychopharmacology (Berlin) 64 (1979) 85-88
3. Baratti C.M., and Kopf S.R. The post-training memory enhancement induced by physostigmine and oxotremorine in mice is not state-dependent. Neurobiology of Learning and Memory 65 (1996) 121-124
4. Beydoun A., Uthman B.M., and Sackellares J.C. Gabapentin: pharmacokinetics, efficacy, and safety. Clinical Neuropharmacology 18 (1995) 469-481
5. Blake M.G., Boccia M.M., Acosta G.B., and Baratti C.M. Posttraining administration of pentylenetetrazol dissociates gabapentin effects on memory consolidation from that on memory retrieval process in mice. Neuroscience Letters 368 (2004) 211-215
6. Boccia M.M., Acosta G.B., and Baratti C.M. Memory improving actions of gabapentin in mice: possible involvement of central muscarinic cholinergic mechanism. Neuroscience Letters 311 (2001) 153-156
7. Boccia M.M., Blake M.G., Acosta G.B., and Baratti C.M. Atropine, an anticholinergic drug, impairs memory retrieval of a high consolidated avoidance response in mice. Neuroscience Letters 345 (2003) 97-100
8. Boccia M.M., Blake M.G., Acosta G.B., and Baratti C.M. Memory consolidation and reconsolidation of an inhibitory avoidance response in mice. Effects of i.c.v. injections of hemicholinium-3. Neuroscience 124 (2004) 735-741
9. Boccia M.M., Blake M.G., Acosta G.B., and Baratti C.M. Memory consolidation and reconsolidation of an inhibitory avoidance task in mice. Effects of a new different learning task. Neuroscience 135 (2005) 19-29
10. Cañadillas-Hidalgo F.M. The safety and tolerability profile of gabapentin in optimal doses. Revista de Neurología 39 (2004) 371-380
11. Castel-Branco M., Lebre V., Falcao A., Figueiredo I., and Caramona M. Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats. European Journal of Pharmacology 482 (2003) 163-168
12. Chouinard G., Beauclair L., and Bélanger M.C. Gabapentin: long-term antianxiety and hypnotic effects in psychiatric patients with comorbid anxiety-related disorders. Canadian Journal of Psychiatry 43 (1998) 305
13. Cilio M.R., Bolanos A.R., Liu Z., Schmid R., Yang Y., Stafstrom C.E., et al. Anticonvulsant action and long-term effects of gabapentin in the immature brain. Neuropharmacology 40 (2001) 139-147
14. Dichter M.A., and Brodie M.J. New antiepileptic drugs. New England Journal of Medicine 13 (1996) 1583-1590
15. Dodrill C.B. Behavioral effects of antiepileptic drugs. Advances in Neurology 55 (1991) 213-224
16. Dodrill C.B., Arnett J.L., Hayes A.G., Garofalo E.A., Greeley C.A., Greiner M.J., et al. Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Research 35 (1999) 109-121
17. Dudai Y., and Eisenberg M. Rites of passage of the engram: reconsolidation and the lingering consolidation hypothesis. Neuron 44 (2004) 93-100
18. 3H]-dopa in various regions of the brain. Journal of Neurochemistry 13 (1966) 655-669
19. Izquierdo I., and McGaugh J.L. Behavioural pharmacology and its contribution to the molecular basis of memory consolidation. Behavioural Pharmacology 11 (2000) 517-534
20. Kwan P., Sills G.J., and Brodie M.J. The mechanisms of action of commonly used antiepileptic drugs. Pharmacology & Therapeutics 90 (2001) 21-34
21. Lowry O.H., Rosenbrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
22. Magnus L. Nonepileptic uses of gabapentin. Epilepsia 40 Suppl. 6 (1999) S66-S72
23. McGaugh J.L. Time-dependent processes in memory storage. Science 153 (1966) 1351-1358
24. McGaugh J.L. Drug facilitation of learning and memory. Annual Review of Pharmacology and Toxicology 13 (1973) 229-241
25. McGaugh J.L. Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Research Bulletin 23 (1989) 339-345
26. Meador K.J., Loring D.W., Ray P.G., Murro A.M., King D.W., Nichols M.E., Deer E.M., and Goff W.T. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 40 (1999) 1279-1285
27. Motamedi G.K., and Meador K.J. Antiepileptic drugs and memory. Epilepsy & Behavior 5 (2004) 435-439
28. Ortinski P., and Meador K.J. Cognitive side effects of antiepileptic drugs. Epilepsy & Behavior 5 Suppl. 1 (2004) S60-S65
29. Pollack M.H., Matthews J., and Scott E.L. Gabapentin as a potential treatment for anxiety disorders. American Journal of Psychiatry 155 (1998) 992-993
30. Rerup C., and Lundquist I. Blood glucose level in mice. Evaluation of a new technique of multiple serial sampling. Acta Endocrinologica (Copenhague) 52 (1966) 357-367
31. Reynolds E.H. Chronic antiepileptic toxicity: a review. Epilepsia 16 (1975) 319-352
32. Rodgers R.J., and Cole J.C. Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behavioural Pharmacology 6 (1995) 283-289
33. Roldán G., Bolaños-Badillo E., González-Sánchez H., Quirarte G.L., and Prado-Alcalá R.A. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats. Neuroscience Letters 18 (1997) 93-96
34. Roldán G., Cobos-Zapiaín G., Quirarte G.L., and Prado-Alcalá R.A. Dose- and time-dependent scopolamine-induced recovery of an inhibitory avoidance response alter its extinction in rats. Behavioural Brain Research 121 (2001) 173-179
35. Siegel S. Non-parametric statistics for the behavioral sciences (1956), McGraw-Hill, New York
36. Singh L., Field M.J., Ferris P., Hunter J.C., Oles R.J., Williams R.G., and Woodruff G.N. The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berlin) 127 (1996) 1-9
37. Tang P.H., Miles M.V., Glauser T.A., and DeGrauw T. Automated microanalysis of gabapentin in human serum by high-performance liquid chromatography with fluorometric detection. Journal of Chromatography. B, Biomedical Sciences and Applications 727 (1999) 125-129
38. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research 29 (1998) 233-249
39. Terry A.V., and Buccafusco J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. The Journal of Pharmacology and Experimental Therapeutics 306 (2003) 821-827
40. Vajda F.J.E. Gabapentin. In: Eadie M.J., and Vajda F.J.E. (Eds). Antiepileptic drugs pharmacology and therapeutics (1999), Springer, Berlin 425-446
41. Vermeulen J., and Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Research 22 (1995) 65-95
42. Winer B.J. Statistical principles in experimental design. 2nd ed. (1971), McGraw-Hill, New York